Large amounts of amyloid plaque have been found in the brains of all Alzheimer’s patients when an autopsy has been performed. This plaque is called beta-amyloid protein and referred to by scientists as “Abeta.” In the current search for anti-Alzheimer’s Disease drugs, researchers have been intensively studying what they call “amyloidism,” 
with a focus on finding ways to modify the process of accumulation of Abeta in the brain. The scientists have uncovered four paths to prevent or stop Abeta accumulation in the brain: (i) reduction of Abeta production; promotion of the Abeta degrading catabolic pathway; (iii) immunotherapy for Abeta and (iv) inhibition of Abeta aggregation.
In investigating the fourth avenue of research – how to inhibit the accumulation or aggregation of Abeta, attention has been focused both on chemical compounds developed in the laboratory and on compounds found in botanicals which can chemically bind the plaque so that it can be excreted or eliminated out of the body through the bowel. Several studies have been performed on the binding capacity of compounds found in Cat’s Claw (Uncaria tomentosa) to Abeta with promising results.
Click here to see some scientific studies relating to Cat’s Claw and Alzheimer’s Disease.
About Royal Cat’s Claw
Our Royal Cat’s Claw products
About Royal Cat's Claw
Our Royal Cat's Claw products
